JAK2 and myeloproliferative neoplasm: In this study we aimed to investigate the variation of CALR-mutant burden during follow-up in CALR-mutant MPN and to compare it to the variation of JAK2 V617F-mutant burden in JAK2-mutant MPN matched for diagnosis.